JPMorgan downgraded Afya (AFYA) to Neutral from Overweight with a price target of $22, down from $24.50. The firm says the company benefits less from the easing cycle in Brazil relative to peers. JPMorgan updated estimates on Brazil education companies post the Q3 results and adjusted preferences for 2026.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AFYA:
- Afya Limited Announces Upcoming Board of Directors Change
- Afya price target lowered to $22 from $25.50 at BofA
- Afya Limited’s Earnings Call Highlights Robust Growth
- Afya’s Balanced Outlook: Revenue Growth Amidst Potential Challenges Justifies Hold Rating
- Afya Limited Reports Strong Growth in Q3 2025